Today: 9 June 2026
Rocket Lab stock rises as traders revisit Space Force satellite deal after Friday slump

Rocket Lab stock rises as traders revisit Space Force satellite deal after Friday slump

NEW YORK, December 29, 2025, 11:50 ET — Regular session

Rocket Lab Corp shares rose 1.6% to $71.78 by 11:50 a.m. ET, rebounding from an 8.5% slide in the prior session. The stock traded between $69.32 and $72.74 on Monday, and has ranged from $14.72 to $79.83 over the past 52 weeks. The Nasdaq was down 0.7% and the S&P 500 fell 0.5%.

The move comes as year-end trading thins out and price swings widen in some high-momentum names. Rocket Lab has been one of the more volatile space-linked stocks this month as investors weigh defense contract wins against near-term execution and spending.

That debate sharpened after the Space Development Agency, part of the U.S. Space Force, said it reached agreements with four suppliers to build 72 missile-warning and tracking satellites in a program worth about $3.5 billion. Lockheed Martin, L3Harris Technologies, Northrop Grumman and Rocket Lab signed fixed-price contracts, Reuters reported, with launches expected in 2029.

Rocket Lab disclosed in an SEC filing that it entered an agreement through a subsidiary to design, manufacture and provide operations and sustainment for 18 satellites for the agency’s Tracking Layer Tranche 3 program. The contract has a total value of $816 million, including an $806 million base amount plus options, and final delivery of the satellites is expected in 2029, the filing showed.

Rocket Lab founder and CEO Peter Beck said in the company’s press release that it was “honored to play a role” in the effort. Rocket Lab said the satellites will include its Phoenix infrared sensor payload and StarLite protection sensors, and it flagged additional subsystem opportunities that could lift total “capture value” to about $1 billion; the company also pointed to an earlier $515 million SDA award, saying the agency has now awarded Rocket Lab more than $1.3 billion in contract value. SEC

Fixed-price contracts pay a set amount for the work, leaving suppliers to absorb cost overruns if schedules slip or parts get more expensive. Investors often view them as a test of execution discipline, especially when production has to scale quickly.

The SDA timeline runs well beyond typical quarterly reporting cycles, which keeps focus on nearer-term signals such as hiring, factory throughput and milestones that can be tracked before revenue builds in a meaningful way. Any updates on cost and schedule will matter as investors handicap margins on large defense programs.

Rocket Lab’s expanding role also puts it in more direct competition with established aerospace and defense contractors on satellite programs, even as it continues to sell launch services and space components. Traders will be watching whether Monday’s bounce holds as portfolios are rebalanced into year-end.

Rocket Lab’s next earnings report is expected on Feb. 26, 2026, according to Zacks Investment Research.

For now, the stock is trying to stabilize after last week’s sharp pullback, with the broader market softer and liquidity still patchy into the final days of 2025.

Stock Market Today

  • NSE Allocates 10% of Annual CSR Fund to Social Stock Exchange
    June 9, 2026, 10:16 AM EDT. The National Stock Exchange (NSE) will deploy 10% of its annual Corporate Social Responsibility (CSR) corpus through the Social Stock Exchange, signaling trust in this market-based platform designed to connect social enterprises with investors. This move aims to enhance transparency and impact investing by leveraging the exchange's resources to support social causes.

Latest articles

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

Regentis Biomaterials Stock: Tiny RGNT Is Back In Focus Before The Bell

9 June 2026
Regentis Biomaterials shares dipped 2 cents to $1.28 premarket after the company announced European surgeon training for its GelrinC knee implant will begin in Q3, marking a key commercial step but leaving investors waiting for revenue proof as the stock trades far below its $8 IPO price.
IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

IREN Stock Approaches $60 as AI Data-Center Bet Hits Key Point

9 June 2026
IREN surged 8.9% to $59.19 and was quoted higher premarket after a bitcoin rebound and renewed focus on its pivot to AI cloud infrastructure, but the stock remains exposed to bitcoin swings, heavy spending, and risks tied to its new 800MW South Australia data center project and major contracts with Nvidia and Microsoft.
AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

AT&T Moves Higher Pre-Market on $45 Billion Payout Plan Still in Focus

9 June 2026
AT&T shares edged up to $22.58 pre-market after reaffirming 2026 guidance and a $45B+ shareholder return plan, providing a cash-flow marker as satellite broadband competition looms; the stock remains pressured by SpaceX risks flagged by Oppenheimer, with second-quarter free cash flow seen at $4.0–$4.5B.
GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386
Previous Story

Tesla stock slips as supplier guts $2.9 bln battery deal to $7,386

MongoDB stock slides as “MongoBleed” exploitation warning puts database security in focus
Next Story

MongoDB stock slides as “MongoBleed” exploitation warning puts database security in focus

Go toTop